CORCEPT THERAPEUTICS INC Shares Outstanding
CORCEPT THERAPEUTICS INC (CORT) had Shares Outstanding of 105.97 million shares as of 2025-12-31, per its 10-K filed 2026-02-24.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-02-24
- 2025-12-31: Shares outstanding (split-adjusted) 105.97M shares; Shares authorized (split-adjusted) 280.00M shares.
- 2024-12-31: Shares outstanding (split-adjusted) 105.11M shares; Shares authorized (split-adjusted) 280.00M shares.
- 2023-12-31: Shares outstanding (split-adjusted) 103.41M shares; Shares authorized (split-adjusted) 280.00M shares.
- 2022-12-31: Shares outstanding (split-adjusted) 107.83M shares; Shares authorized (split-adjusted) 280.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2025-12-31 | 105.97M shares 10-K · filed 2026-02-24 | 280.00M shares 10-K · filed 2026-02-24 |
| 2024-12-31 | 105.11M shares 10-K · filed 2026-02-24 | 280.00M shares 10-K · filed 2026-02-24 |
| 2023-12-31 | 103.41M shares 10-K · filed 2025-02-26 | 280.00M shares 10-K · filed 2025-02-26 |
| 2022-12-31 | 107.83M shares 10-K · filed 2024-02-15 | 280.00M shares 10-K · filed 2024-02-15 |
| 2021-12-31 | 105.94M shares 10-K · filed 2023-02-28 | 280.00M shares 10-K · filed 2023-02-28 |
| 2020-12-31 | 116.73M shares 10-K · filed 2022-02-15 | 280.00M shares 10-K · filed 2022-02-15 |
| 2019-12-31 | 114.55M shares 10-K · filed 2021-02-23 | 280.00M shares 10-K · filed 2021-02-23 |
| 2018-12-31 | 115.03M shares 10-K · filed 2020-02-24 | 280.00M shares 10-K · filed 2020-02-24 |
| 2017-12-31 | 114.72M shares 10-K · filed 2019-02-26 | 280.00M shares 10-K · filed 2019-02-26 |
| 2017-09-30 | 114.08M shares 10-Q · filed 2017-11-03 | 280.00M shares 10-Q · filed 2017-11-03 |
| 2017-06-30 | 113.36M shares 10-Q · filed 2017-08-02 | 280.00M shares 10-Q · filed 2017-08-02 |
| 2017-03-31 | 113.11M shares 10-Q · filed 2017-05-02 | 280.00M shares 10-Q · filed 2017-05-02 |
| 2016-12-31 | 112.71M shares 10-K · filed 2018-02-28 | 280.00M shares 10-K · filed 2018-02-28 |
| 2016-09-30 | 110.88M shares 10-Q · filed 2016-11-02 | 280.00M shares 10-Q · filed 2016-11-02 |
| 2016-06-30 | 110.48M shares 10-Q · filed 2016-08-03 | 280.00M shares 10-Q · filed 2016-08-03 |
| 2016-03-31 | 109.67M shares 10-Q · filed 2016-05-04 | 280.00M shares 10-Q · filed 2016-05-04 |
| 2015-12-31 | 109.64M shares 10-K · filed 2017-03-06 | 280.00M shares 10-K · filed 2017-03-06 |
| 2015-09-30 | 108.75M shares 10-Q · filed 2015-11-06 | 280.00M shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 108.23M shares 10-Q · filed 2015-08-07 | 280.00M shares 10-Q · filed 2015-08-07 |
| 2015-03-31 | 107.72M shares 10-Q · filed 2015-05-08 | 280.00M shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 101.39M shares 10-K · filed 2016-03-10 | 280.00M shares 10-K · filed 2016-03-10 |
| 2014-09-30 | 101.14M shares 10-Q · filed 2014-11-07 | 280.00M shares 10-Q · filed 2014-11-07 |
| 2014-06-30 | 101.12M shares 10-Q · filed 2014-08-08 | 280.00M shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | 100.69M shares 10-Q · filed 2014-05-12 | 280.00M shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 99.85M shares 10-K · filed 2015-03-13 | 280.00M shares 10-K · filed 2015-03-13 |
| 2013-09-30 | 99.81M shares 10-Q · filed 2013-11-12 | 280.00M shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 99.81M shares 10-Q · filed 2013-08-09 | 280.00M shares 10-Q · filed 2013-08-09 |
| 2013-03-31 | 99.81M shares 10-Q · filed 2013-05-08 | 280.00M shares 10-Q · filed 2013-05-08 |
| 2012-12-31 | 99.81M shares 10-K · filed 2014-03-14 | 280.00M shares 10-K · filed 2014-03-14 |
| 2012-06-13 | (m) | 280.00M shares 10-K · filed 2013-03-15 |
| 2011-12-31 | 84.23M shares 10-K · filed 2013-03-15 | 140.00M shares 10-K · filed 2013-03-15 |
| 2010-12-31 | 72.40M shares 10-K · filed 2012-03-13 | 140.00M shares 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |